Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dipak Delvadia

Obstetrics & Gynecology Cherry Hill, NJ Doctor of Osteopathy

NPI 1386624773 CMS profile 17041

1945 Route 70 E Ste C, Cherry Hill, NJ 08003

Open in the dashboard

General payments

$86,264

140 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$13,818 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Dipak Delvadia of Cherry Hill, NJ is reported in the CMS Open Payments database as having received $86,264 across 140 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $13,818 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,608 13
2024 General $17,357 15
2023 General $2,834 5
2022 General $21,050 40
2021 General $12,261 26
2020 General $6,716 20
2019 General $9,438 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dipak Delvadia
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Dipak Delvadia were reported at $16,608. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Dipak Delvadia Obstetrics & Gynecology median Middle half National median
2019 $9,438 $172 $62–$391 $163
2020 $6,716 $94 $36–$222 $114
2021 $12,261 $136 $42–$369 $132
2022 $21,050 $160 $50–$433 $149
2023 $2,834 $169 $56–$423 $160
2024 $17,357 $152 $50–$371 $164
2025 $16,608 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organon LLC $45,229 57 payments
  2. Gynesonics, Inc. $22,213 27 payments
  3. Merck Sharp & Dohme Corporation $14,483 24 payments
  4. Ethicon Inc. $2,762 3 payments
  5. AbbVie, Inc. $547 11 payments
  6. Cytyc Surgical Products, LLC $385 1 payment
  7. Hologic, LLC $181 3 payments
  8. Channel Medsystems, Inc. $117 1 payment
  9. Ethicon US, LLC $88 2 payments
  10. Coloplast Corp $81 1 payment
  11. Other $177 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $37,642 41 payments
  2. Consulting Fee $21,263 11 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $21,000 15 payments
  4. Food and Beverage $3,079 55 payments
  5. Travel and Lodging $2,340 17 payments
  6. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $940 1 payment
Products named General payments · program years 2019–2025
  1. NEXPLANON Etonogestrel $33,690 45 payments
  2. NEXPLANON Womens Health $14,483 24 payments
  3. Sonata Sonography-Guided Transcervical Fibroid Ablation System Surgical $9,732 3 payments
  4. SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM Sonata Transcervical Fibroid Ablation System $9,436 11 payments
  5. Nexplanon Womens Health $7,413 9 payments
  6. DERMABOND $2,762 3 payments
  7. Sonata System $2,311 6 payments
  8. SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM Gynecology $555 6 payments
  9. Orilissa $344 4 payments
  10. Sontata System $179 1 payment
  11. Other $1,294 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

23

Median for Obstetrics & Gynecology: 65

Drug cost

$1,443

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

0%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 23 $1,443

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$2,548

Medicare's payments for the services billed

Medicare patients

26

Average age 59

Services billed

40

26 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 46%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record